RNA disruption indicates CHOP therapy efficacy in canine lymphoma.
Amadeo M ParissentiLaura B PritzkerBaoqing GuoRashmi NarendrulaShirly Xiaohui WangLin Laura LinJingchun PeiKarolina SkowronskiDorothee BienzleJ Paul WoodsKenneth P H PritzkerBrenda L CoomberPublished in: BMC veterinary research (2019)
Predicting the risk of early relapse during chemotherapy could benefit veterinary patients by reducing ineffective treatment and could allow veterinary oncologists to switch earlier to a more effective drug regimen.